ADAMTS13 and thrombotic thrombocytopenic purpura: A limitation of all animal models of acquired TTP however, is that injection of the inhibitory anti-ADAMTS13 antibodies does not reflect the continuous production of anti-ADAMTS13 antibodies as in acquired TTP patients.